Long-term immune memory in SVP-treated TC-1 survivors.

<p>Mice treated with SVP[E7/6*] and SVP[poly(I:C)] as shown in C were (A) re-challenged at day 158 after the first TC-1 inoculation and once again 154 days later (shown by arrows) or (B) sacrificed on day 265 after initial TC-1 inoculation, and their splenocytes inoculated into naïve mice (10⁸/mouse, i.v.), which 8 days later were inoculated with TC-1 cells (8 mice/each group). No further treatment was applied.